These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2664200

  • 21. The effects of chronic bacteremia on the metabolic response to exercise in the conscious rat.
    Musch TI, Martin LF.
    Circ Shock; 1988 Aug; 25(4):245-58. PubMed ID: 3048770
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA, Quinto J, Kao J, Rotstein OD.
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I, Ledney GD.
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sepsis-induced myofibrillar protein catabolism in rat skeletal muscle.
    Ahmad S, Karlstad MD, Choudhry MA, Sayeed MM.
    Life Sci; 1994 Feb; 55(18):1383-91. PubMed ID: 7934649
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R, Gupta U, Watanabe K, Ueno K.
    Microbiol Immunol; 1992 Feb; 36(10):1041-9. PubMed ID: 1479960
    [Abstract] [Full Text] [Related]

  • 31. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator.
    Rotstein OD, Kao J.
    J Infect Dis; 1988 Oct; 158(4):766-72. PubMed ID: 3139778
    [Abstract] [Full Text] [Related]

  • 32. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD, Pruett TL, Simmons RL.
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
    van Goor H, de Graaf JS, Kooi K, Sluiter WJ, Bom VJ, van der Meer J, Bleichrodt RP.
    J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I.
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anaerobic infection of the liver and biliary tract in experimental common duct occlusion.
    Justesen T, Nielsen ML.
    Scand J Infect Dis Suppl; 1979 Oct; (19):35-41. PubMed ID: 379988
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.